Article
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.
The New England journal of medicine - 22 Mar 2012
Patel Jay P, Gönen Mithat, Figueroa Maria E, Fernandez Hugo, Sun Zhuoxin, Racevskis Janis, Van Vlierberghe Pieter, Dolgalev Igor, Thomas Sabrena, Aminova Olga, Huberman Kety, Cheng Janice, Viale Agnes, Socci Nicholas D, Heguy Adriana, Cherry Athena, Vance Gail, Higgins Rodney R, Ketterling Rhett P, Gallagher Robert E, Litzow Mark, van den Brink Marcel R M, Lazarus Hillard M, Rowe Jacob M, Luger Selina, Ferrando Adolfo, Paietta Elisabeth, Tallman Martin S, Melnick Ari, Abdel-Wahab Omar, Levine Ross L
Abstract excerpt
BACKGROUND: Acute myeloid leukemia (AML) is a heterogeneous disease with respect to presentation and clinical outcome. The prognostic value of recently identified somatic mutations has not been systematically evaluated in a phase 3 trial of treatment for AML. METHODS: We performed a mutational analysis of 18 genes in 398 patients younger than 60 years of age who had AML and who were randomly assigned to receive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
